Clinical Trials for Myelodysplastic Syndromes (MDS)
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Myelodysplastic Syndromes (MDS)
Our cancer specialists provide advanced treatments for myelodysplastic syndromes (MDS), a group of blood disorders, including stem cell transplant.
Myelodysplastic Syndromes MDS myelodysplasia